期刊文献+

围绝经期女性代谢综合征的相关研究进展 被引量:40

Advances in Research on Metabolic Syndrome in Perimenopausal Women
下载PDF
导出
摘要 代谢综合征(MS)严重威胁围绝经期女性的健康和生活质量。糖尿病、血脂异常是其重要的组成部分,其中心环节是腹型肥胖和胰岛素抵抗。围绝经期女性由于卵巢功能的衰退,性激素水平发生一系列改变,对血脂代谢和骨密度均有一定的影响。但该阶段女性发展为MS的具体机制尚未完全阐明。遗传因素和环境因素可影响围绝经期女性MS的发生,个体化生活方式干预和激素替代治疗可以降低绝经妇女MS的发生率。现对女性性激素与MS的关系、MS的流行概况、治疗和管理等进行综述。 Metabolic syndrome is a serious threat to the health and quality of life of perimenopausal women. Diabetes and dyslipidemia are main parts of it,its central link is abdominal obesity and insulin resistance. Due to the decline of ovarian function,sex hormone levels of perimenopausal women have a series of changes, which have a certain impact on lipid metabolism and bone mineral density. However, the specific mechanism of women developing MS at this stage has not been fully clarified. Genetic factors and environmental factors may be related to the occurrence of MS in perimenopausal women. Individualized life style interventions and hormone replacement therapy can reduce the incidence of MS in postmenopausal women. This article reviews the relationship between female sex hormones and MS, the prevalence, treatment as well as management of MS.
作者 黄志英 丁岩 HUANG Zhi-ying;DING Yan(The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830011,China)
出处 《国际妇产科学杂志》 CAS 2020年第1期84-87,共4页 Journal of International Obstetrics and Gynecology
基金 国家自然科学基金项目(81660249)
关键词 围绝经期 代谢综合征X 雌激素类 受体 雌激素 雄激素类 Perimenopause Metabolic syndrome X Estrogens Receptors,estrogen Androgens
  • 相关文献

参考文献4

二级参考文献50

  • 1孙曙光,勾美图.围绝经期和绝经后妇女应用激素替代治疗2年后血脂蛋白和载脂蛋白的变化[J].中国临床康复,2005,9(11):54-55. 被引量:8
  • 2宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:611
  • 3顾东风,Reynolds K,杨文杰,陈恕凤,吴锡桂,段秀芳,蒲晓东,徐丽华,吴先萍,陈祥福,魏仁敏,陈娜萦,吴天一,王礼桂,姚才良,牟建军,马义峰,王晓飞,Whelton P,何江.中国成年人代谢综合征的患病率[J].中华糖尿病杂志(1006-6187),2005,13(3):181-186. 被引量:580
  • 4Alberti KG, Zimmet P, ShawJ. The metabolic syndrome a new world-wide definition[J]. Lancent, 2005,366(9491): 1059-1062.
  • 5Mathieu P, DespresJ P, Pibarot P. The 'valvulo-metabol?ic' risk in calcific aortic valve disease[J]. CanJ Cardiol, 2007,23 (Suppl B) :32B -39B.
  • 6Leuzzi C, Marzullo R, Modena MG. Is meno pause a risk factor for ischemic heart disease in women?[J]. G Ital Cardiol, 2012,13 (6) :401-406.
  • 7Ijuin H, Douchi T, Oki T, et al. The contribution of meno?pause to changes in body-fat distribution[J].J Obstet Gynaecol Res,1999,25(5) :367-372.
  • 8Bittner V. Menopause, age, and cardiovascular risk: a complex relationship[J]. Am ColI Cardiol, 2009,54 ( 25) : 2374-2375.
  • 9Coylewright M, ReckelhoffJ F, Ouyang P. Menopause and hypertension: an age-old debate[J]. Hypertension, 2008, 51(4) :952-959.
  • 10Kim E S, Menon V. Status of women in cardiovascular clin?ical trials[J]. Arterioscler Thromb Vasc BioI, 2009, 29 (3) :279-283.

共引文献193

同被引文献483

引证文献40

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部